On February 24, the Outsourcing Facilities Association, a compounding industry group, and a compounding pharmacy operator sued the FDA in federal court in Texas
According to the article, Congress created limited exemptions allowing pharmacies to compound certain drugs under FDCA 503A and 503B, but those provisions do not explicitly address whether the exemptions shield compounders from patent infringement claims
GLP-1 Compliance during Shortages: GLP-1 medications have been in high demand, leading to gaps in compliance
It binds to and stimulates GHRH receptors with similar potency as endogenous GHRH
Unlike natural IGF-1, IGF-1 LR3 was designed with an extended half-life and increased bioavailability, allowing for prolonged biological activity and enhanced therapeutic potential
Color Change: It should be clear and colorless